Cell entry mechanisms of SARS-CoV-2

Cited by (1,003)

Items 701–800 of 1,003

1. Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection
   Ivonne Melano, Li-Lan Kuo, Yan-Chung Lo, Po-Wei Sung, Ni Tien, Wen‐Chi Su · 2021 · Viruses
2. Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction
   Javeed Ahmad, Jiansheng Jiang, Lisa F. Boyd, Allison Zeher, Rick K Huang, Di Xia, Kannan Natarajan, David H. Margulies · 2021 · Journal of Biological Chemistry
3. Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study
   Souvik Banerjee, Shalini Yadav, Sourav Banerjee, Sayo Olawale Fakayode, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Foyez Mahmud, Ryan Whatcott, Joshua Thammathong et al. · 2021 · Journal of Chemical Information and Modeling
4. Advanced Materials for SARS‐CoV‐2 Vaccines
   Moustafa T. Mabrouk, Wei‐Chiao Huang, Luis Martínez‐Sobrido, Jonathan F. Lovell · 2021 · Advanced Materials
5. Dynamical demeanour of SARS-CoV-2 virus undergoing immune response mechanism in COVID-19 pandemic
   Jayanta Mondal, Piu Samui, Amar Nath Chatterjee · 2022 · The European Physical Journal Special Topics
6. The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
   Eugenie Ruth Lumbers, Richard J. Head, Gary R. Smith, Sarah J. Delforce, Bevyn Jarrott, Jennifer H. Martin, Kirsty G. Pringle · 2022 · Pharmacology Research & Perspectives
7. Genetic Landscape of the ACE2 Coronavirus Receptor
   Zhijian Yang, Erin Macdonald-Dunlop, Jiantao Chen, Ranran Zhai, Ting Li, Anne Richmond, Lucija Klarić, Nicola Pirastu, Zheng Ning, Chenqing Zheng et al. · 2022 · Circulation
8. Different Aspects of Emetine’s Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19
   Mehdi Valipour · 2022 · ACS Pharmacology & Translational Science
9. SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion
   Jianchao Zhang, Andrew A. Kennedy, Daniel Macedo de Melo Jorge, Lijuan Xing, Whitney Reid, Sarah Bui, Joseph Joppich, Molly Rose, Sevval Ercan, Qiyi Tang et al. · 2025 · PLoS Pathogens
10. Should we discount the laboratory origin of COVID-19?
    Rossana Segreto, Yuri Deigin, Kevin McCairn, Alejandro Sousa, Dan Sirotkin, Karl M. Sirotkin, Jonathan J. Couey, Adrian Jones, Daoyu Zhang · 2021 · Environmental Chemistry Letters
11. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
    Kruglova, Natalia, Siniavin, Andrei, Gushchin, Vladimir, Mazurov, Dmitriy · 2021 · Viruses
12. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture
    Christian Shema Mugisha, Hung R. Vuong, Maritza Puray‐Chavez, Adam L. Bailey, Julie M. Fox, Rita E. Chen, Alex W. Wessel, Jason M. Scott, Houda Harastani, Adrianus C. M. Boon et al. · 2020 · mSphere
13. Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike
    John James Baczenas, Hanné Andersen, Sujatha Rashid, David A. Yarmosh, Nikhita P. Puthuveetil, Michael L. Parker, Rebecca Bradford, Clint Florence, Kimberly J. Stemple, Mark G. Lewis et al. · 2021 · Viruses
14. The past, current and future epidemiological dynamic of SARS-CoV-2
    François Balloux, Cedric C.S. Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala K. Maini, Lucy van Dorp · 2022 · Oxford Open Immunology
15. Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
    SubbaRao V. Tulimilli, Siva Dallavalasa, Chaithanya G. Basavaraju, Vinay Kumar Rao, Prashanth Chikkahonnaiah, SubbaRao V. Madhunapantula, Ravindra P. Veeranna · 2022 · Vaccines
16. microRNAs as new possible actors in gender disparities of Covid‐19 pandemic
    Giada Pontecorvi, Maria Bellenghi, Elena Ortona, Alessandra Carè · 2020 · Acta Physiologica
17. Potential diagnostics and therapeutic approaches in COVID-19
    Pratibha Kumari, Archana Kumari Singh, Moses Rinchui Ngasainao, Ilma Shakeel, Sanjay Kumar, Seema Lal, Anchal Singhal, Sukhwinder Singh Sohal, Indrakant Kumar Singh, Md. Imtaiyaz Hassan · 2020 · Clinica Chimica Acta
18. Recent Insights into Emerging Coronavirus: SARS-CoV-2
    Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang · 2020 · ACS Infectious Diseases
19. Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19
    Aditya Sahai, Rohan Bhandari, Matthew Godwin, Thomas M. McIntyre, Mina K. Chung, Jean‐Pierre Iskandar, Hayaan Kamran, Essa H. Hariri, Anu Aggarwal, Robert Burton et al. · 2021 · Vascular Medicine
20. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses
    Morvarid Siri, Sanaz Dastghaib, Mozhdeh Zamani, Nasim Rahmani-Kukia, Kiarash Roustai Geraylow, Shima Fakher, Fatemeh Keshvarzi, Parvaneh Mehrbod, Mazaher Ahmadi, Pooneh Mokarram et al. · 2021 · International Journal of Molecular Sciences
21. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative
    Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, Sara Khaleeq, Petrus Jansen van Vuren, Shane Riddell, Sarah Goldie et al. · 2021 · ACS Infectious Diseases
22. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes
    Titilola D. Kalejaiye, Rohan Bhattacharya, Morgan A. Burt, Tatianna Travieso, Arinze Emmanuel Okafor, Xingrui Mou, Maria Blasi, Samira Musah · 2022 · Frontiers in Cell and Developmental Biology
23. IgG N-glycome changes during the course of severe COVID-19: An observational study
    Tea Petrović, Amrita Vijay, Frano Vučković, Irena Trbojević‐Akmačić, Ben J. Ollivere, Damir Marjanović, Tamer Bego, Besim Prnjavorac, Lovorka Đerek, Alemka Markotić et al. · 2022 · EBioMedicine
24. Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition
    Ju‐Ri Sim, Dong Hoon Shin, Pil‐Gu Park, Sohyeon Park, Joon‐Yong Bae, Youngchae Lee, Dha-Yei Kang, Ye Jin Kim, Sowon Aum, Shin Hye Noh et al. · 2022 · Cell Reports
25. Long-Term Sequelae of COVID-19 in Experimental Mice
    Michael John Paidas, Daniela S. Cosio, Saad Ali, Norma Sue Kenyon, Arumugam Radhakrishnan Jayakumar · 2022 · Molecular Neurobiology
26. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA‐dependent RNA polymerase of wild‐type and Delta subvariant AY.4 of SARS‐CoV‐2
    İsmail Çeli̇k, Trina Ekawati Tallei · 2022 · Journal of Cellular Biochemistry
27. Glycosylation in SARS-CoV-2 variants: A path to infection and recovery
    Arya Aloor, Rajaguru Aradhya, Parvathy Venugopal, Bipin Gopalakrishnan Nair, Renuka Suravajhala · 2022 · Biochemical Pharmacology
28. Deciphering the Relationship between SARS-CoV-2 and Cancer
    Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello · 2023 · International Journal of Molecular Sciences
29. ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
    Melanie Engler, Dan Albers, Pascal von Maltitz, Rüdiger M. Groß, Jan Münch, Ion Cristian Cirstea · 2023 · Life Science Alliance
30. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
    R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti · 2024 · Annual Review of Immunology
31. Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, Olea europaea L., in Long COVID and Other Conditions Involving Cognitive Impairment
    Paraskevi Papadopoulou, Alexia Polissidis, Georgia Kythreoti, Marina Sagnou, Athena Stefanatou, Theoharis Constantin Theoharides · 2024 · International Journal of Molecular Sciences
32. Decoding mechanisms and protein markers in lung-brain axis
    Shiqian Huang, Yuxi Zhou, Haipeng Ji, Tianhao Zhang, Shiya Liu, Lulin Ma, Daling Deng, Yuanyuan Ding, Linlin Han, Shaofang Shu et al. · 2025 · Respiratory Research
33. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein
    Pengfei Pei, Hongbo Qin, Jialin Chen, Fengli Wang, Chengzhi He, Shiting He, Bixia Hong, Ke Liu, Renzhong Qiao, Huahao Fan et al. · 2021 · Briefings in Bioinformatics
34. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
    Zhen-Lin Yang, Yulu Wang, Yu-jia Jin, Yuan-Fei Zhu, Yan-Ling Wu, Cheng Li, Yu Kong, Wen-Ping Song, Xiaolong Tian, Wuqiang Zhan et al. · 2021 · Signal Transduction and Targeted Therapy
35. Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2
    Kapil Gupta, Christine Toelzer, Maia Kavanagh Williamson, Deborah K. Shoemark, A. Sofia F. Oliveira, David A. Matthews, Abdulaziz Almuqrin, Oskar Staufer, Sathish K.N. Yadav, Ufuk Borucu et al. · 2022 · Nature Communications
36. The Impact ofACEandACE2Gene Polymorphisms in Pulmonary Diseases Including COVID-19
    Iphigenia Gintoni, Μαρία Αδαμοπούλου, Christos Yapijakis · 2021 · In Vivo
37. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review
    Jhon Paul Iakov Mezarina Mendoza, Briggitte Trelles, Gabriela Tazziana Salcedo Bolívar, Rosa Del Pilar Castañeda Palacios, Paulo Sergio Gilmar Herrera Lopez, David Alex Padilla Rodríguez, Karin Harumi Uchima Koecklin · 2022 · The Saudi Dental Journal
38. Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment
    Richard J. Head, Eugenie Ruth Lumbers, Bevyn Jarrott, Felix Tretter, Gary Smith, Kirsty G. Pringle, Saiful Islam, Jennifer H. Martin · 2022 · Pharmacology Research & Perspectives
39. Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
    Chulwoo Kim, Jae-Deog Kim, Sang‐Uk Seo · 2022 · The Journal of Microbiology
40. Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy
    William Durante · 2022 · Metabolites
41. UV222 disinfection of SARS-CoV-2 in solution
    Richard Robinson, Najmus Mahfooz, Oscar Rosas Mejia, Yijing Liu, Natalie M. Hull · 2022 · Scientific Reports
42. The bacteriophage decides own tracks: When they are with or against the bacteria
    Salsabil Makky, Alyaa Dawoud, Anan Safwat, Abdallah S. Abdelsattar, Nouran Rezk, Ayman El‐Shibiny · 2021 · Current Research in Microbial Sciences
43. SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody
    Olaposi Idowu Omotuyi, Olujide Oludayo Olubiyi, Oyekanmi Nash, Elizabeth Oluwatoyin Afolabi, Babatunji Emmanuel Oyinloye, Segun Fatumo, Mbang Nyong Femi-Oyewo, Suleiman Bogoro · 2021 · Computers in Biology and Medicine
44. Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses
    Xiuyuan Ou, Ge Zhi Xu, Pei Li, Yan Liu, Fuwen Zan, Pan Liu, Jiaxin Hu, Xing Lu, Siwen Dong, Yao Zhou et al. · 2023 · Cell Discovery
45. A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2
    Cecy Xi, Arianna Di Fazio, Naveed A. Nadvi, Karishma Patel, Michelle Sui Wen Xiang, Hui Emma Zhang, Chandrika N. Deshpande, Jason K. K. Low, Xiaonan Trixie Wang, Yiqian Chen et al. · 2020 · Molecules
46. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic
    Dimitriοs Vlachakis, Eleni Papakonstantinou, Τhanasis Mitsis, Katerina Pierouli, Io Diakou, George Panagiotis Chrousos, Flora Bacopoulou · 2020 · Food and Chemical Toxicology
47. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
    Yongping Yang, Wei Shi, Olubukola M. Abiona, Alexandra F. Nazzari, Adam S. Olia, Li Ou, Emily Phung, Tyler Stephens, Yaroslav Tsybovsky, Raffaello Verardi et al. · 2021 · Vaccines
48. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
    R. Marlin, V. Godot, Sylvain Cardinaud, Mathilde Galhaut, Séverin Coléon, S. Zurawski, N. Dereuddre-Bosquet, M. Cavarelli, Anne-Sophie Gallouët, P. Maisonnasse et al. · 2021 · Nature Communications
49. Single-Molecule FRET Imaging of Virus Spike–Host Interactions
    Maolin Lu · 2021 · Viruses
50. Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
    Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, Moshe Aftalion, Reut Falach, Shani Leviatan Ben‐Arye, Shirley Lazar et al. · 2021 · iScience
51. Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management
    Debmalya Barh, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Sandeep Tiwari, Ángel Serrano‐Aroca, Khalid Jamaan Alzahrani, Bruno Silva Andrade, Vasco Azevedo, Nirmal Kumar Ganguly, Kenneth H. Lundstrom · 2021 · Biomedicines
52. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
    Mark Howell, Ryan J. Green, Andrew R. McGill, Rinku Dutta, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Cancers
53. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases
    Cinzia Sindona, Giovanni Schepici, Valentina Contestabile, Placido Bramanti, Emanuela Mazzon · 2021 · Medicina
54. Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternative Route to Brain Infection in COVID-19
    Katarzyna Bilińska, Christopher S. von Bartheld, Rafał Butowt · 2021 · Frontiers in Cellular Neuroscience
55. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
    Bingqian Li, Lin Wang, Huan Ge, Xianglei Zhang, Pengxuan Ren, Yu Guo, Wuyan Chen, Jie Li, Wei Jian Zhu, Wenzhang Chen et al. · 2021 · Frontiers in Chemistry
56. A Highly Potent SARS-CoV-2 Blocking Lectin Protein
    Recep Erdem Ahan, Alireza Hanifehnezhad, Ebru Ş. Kehribar, Tuba Çiğdem Oğuzoğlu, Katalin Földes, Cemile E. Özçelik, Nazlıcan Filazi, Sıdıka Öztop, Fahreddin Palaz, Sevgen Önder et al. · 2022 · ACS Infectious Diseases
57. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
    Raymond R. R. Rowland, Alberto Brandariz-Núñez · 2021 · Microbiology Spectrum
58. Kinetic Analysis of a Protein-protein Complex to Determine its Dissociation Constant (KD) and the Effective Concentration (EC50) of an Interplaying Effector Molecule Using Bio-layer Interferometry
    Tim Orthwein, Luciano Fernandes Huergo, Karl Forchhammer, Khaled A. Selim · 2021 · BIO-PROTOCOL
59. In Silico Identification of New Anti-SARS-CoV-2 Agents from Bioactive Phytocompounds Targeting the Viral Spike Glycoprotein and Human TLR4
    Nabarun Chandra Das, Rajendra Kumar Labala, Ritwik Patra, Asamanja Chattoraj, Suprabhat Mukherjee · 2021 · Letters in Drug Design & Discovery
60. Aptamers—Diagnostic and Therapeutic Solution in SARS-CoV-2
    Tomasz Wandtke, Ewelina Wędrowska, Marcin Szczur, Grzegorz Przybylski, Marek Libura, Piotr Kopiński · 2022 · International Journal of Molecular Sciences
61. Genetic landscape of the ACE2 coronavirus receptor
    Zhijian Yang, Erin Macdonald-Dunlop, Jiantao Chen, Bram Peter Prins, Eleanor Wheeler, Maik Pietzner, James E. Peters, Claudia Langenberg, Adam S. Butterworth, Alex P. Reiner et al. · 2022 · Apollo (University of Cambridge)
62. mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients
    Zahra Bagheri‐Hosseinabadi, Ebrahim Rezazadeh Zarandi, Mohammad Mirabzadeh, Ali Amiri, Mitra Abbasifard · 2022 · BMC Infectious Diseases
63. CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
    Aishwarya Rajan, Stuti Shrivastava, Janhawi, Akhilesh Kumar, Alok Kumar Singh, Pankaj Kumar Arora · 2022 · Applied Microbiology and Biotechnology
64. Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike
    Diego M. Cantoni, Matthew J Murray, Mphatso D. Kalemera, Samuel J. Dicken, Lenka Stejskal, Georgina Brown, Spyros Lytras, Jonathon D. Coey, James Patrick McKenna, Stephen Bridgett et al. · 2022 · EMBO Reports
65. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications
    Sangiliyandi Gurunathan, Ah Reum Lee, Jin‐Hoi Kim · 2022 · International Journal of Molecular Sciences
66. Impact of glycoscience in fighting Covid-19
    Roberto Adamo, Sandro Sonnino · 2020 · Glycoconjugate Journal
67. The Multisystem Impact of Long COVID: A Comprehensive Review
    Nicoleta Negruţ, Georgios Menegas, Sofia Kampioti, Maria Bourelou, Francesca Kopanyi, Faiso Dahir Hassan, Anamaria Asowed, Fatima Zohra Taleouine, Anca Cristina Ferician, Paula Marian · 2024 · Diagnostics
68. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
    Manisha Yadav, Swasti Dhagat, Satya Eswari · 2020 · European Journal of Pharmaceutical Sciences
69. Impact of SARS-CoV-2 on Male Reproductive Health: A Review of the Literature on Male Reproductive Involvement in COVID-19
    Weihang He, Xiaoqiang Liu, Liang Feng, Situ Xiong, Yulei Li, Luyao Chen, Li Yu, Gongxian Wang, Dongshui Li, Bin Fu · 2020 · Frontiers in Medicine
70. Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
    Nihar Ranjan Jena · 2021 · Chemical Physics Impact
71. Molecular basis for higher affinity of SARS‐CoV ‐2 spike RBD for human ACE2 receptor
    Julián M. Delgado, Nalvi D. Duro, David O. Williams Rogers, Alexandre Tkatchenko, Sagar A Pandit, Sameer Varma · 2021 · Proteins Structure Function and Bioinformatics
72. Milk-derived anti-infectives and their potential to combat bacterial and viral infection
    Sinead T. Morrin, Rachael H. Buck, Michael Farrow, Rita M. Hickey · 2021 · Journal of Functional Foods
73. COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2
    Dabing Li, Xiaoyan Liu, Lianmei Zhang, Jiayue He, Xianmao Chen, Shuguang Liu, Jiewen Fu, Shangyi Fu, Hanchun Chen, Junjiang Fu et al. · 2021 · International Journal of Biological Sciences
74. Pathogenesis of COVID‐19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx
    Heidi N. du Preez, Colleen Aldous, Melvin R. Hayden, Hendrik Gerhardus Kruger, Johnson Lin · 2021 · The FASEB Journal
75. Antiviral properties of whey proteins and their activity against SARS-CoV-2 infection
    Valentina Gallo, Francesco Giansanti, Alyexandra Arienzo, Giovanni Antonini · 2022 · Journal of Functional Foods
76. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality
    Aneta Aleksova, Alessandra Lucia Fluca, Giulia Gagno, Alessandro Pierri, Laura Padoan, Agnese Derin, Rita Moretti, Elena Aleksova Noveska, Eros Azzalini, Stefano D’Errico et al. · 2022 · Life Sciences
77. Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics
    Sean M. Braet, Theresa SC Buckley, Varun Venkatakrishnan, Kim-Marie A. Dam, Pamela J. Björkman, Ganesh S. Anand · 2023 · eLife
78. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis
    V.L. Pecoraro, Michela Cuccorese, Tommaso Trenti · 2023 · Clinical and Experimental Medicine
79. SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathways
    Mizuki Yamamoto, Keiko Tomita, Youko Hirayama, Jun‐ichiro Inoue, Yasushi Kawaguchi, Jin Gohda · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
80. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications
    Prakash Patil, Praveenkumar K. Shetty, Nithin Kuriakose, Pavan Gollapalli, Sukanya Shetty, Roopa Rani Bhandary, Jamboor K. Vishwanatha, Sudeep Darbhe Ghate · 2021 · International Journal of Molecular Sciences
81. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway
    Frédéric Carrière, Sonia Longhi, Michel Record · 2020 · Biochimie
82. 2020 update on human coronaviruses: One health, one world
    Xinbin Zhao, Yuecheng Ding, Jing Du, Yubo Fan · 2020 · Medicine in Novel Technology and Devices
83. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2
    Xiaoqiang Huang, Chengxin Zhang, Robin Pearce, Gilbert S. Omenn, Yang Zhang · 2020 · Journal of Proteome Research
84. Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
    Camille R. Simoneau, Mélanie Ott · 2020 · Cell stem cell
85. A review of COVID-19 biomarkers and drug targets: resources and tools
    Francesca Pia Caruso, Giovanni Scala, Luigi Cerulo, Michele Ceccarelli · 2020 · Briefings in Bioinformatics
86. Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
    Ling Zhu, Yong‐Qiang Deng, Rong-Rong Zhang, Zhen Cui, Chun-Yun Sun, Changfa Fan, Xiaorui Xing, Weijin Huang, Qi Chen, Na-Na Zhang et al. · 2020 · National Science Review
87. Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
    Tiziana Ginex, Urtzi Garaigorta, David Ramírez, Victoria Castro, Vanesa Nozal, Inés Maestro, Javier Garcı́a-Cárceles, Nuria Eugenia Campillo, Ana Martı́nez, Pablo Gastaminza et al. · 2021 · Pharmaceuticals
88. Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19
    Carolin Langnau, Anne‐Katrin Rohlfing, Sarah Gekeler, Manina Günter, Simone Pöschel, Álvaro Petersen-Uribe, Philippa Jaeger, Alban Avdiu, Tobias Harm, Klaus‐Peter Kreißelmeier et al. · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
89. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type
    Anwar Mohammad, Fahd Al‐Mulla, Dong‐Qing Wei, Jehad Ahmed Abubaker · 2021 · Biomolecules
90. A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19
    Ruy Freitas Reis, Alexandre Bittencourt Pigozzo, Carla Rezende Barbosa Bonin, Bárbara de Melo Quintela, Lara Turetta Pompei, Ana Carolina Vieira, Larissa de Lima e Silva, Maicom Peters Xavier, Rodrigo Weber dos Santos, Marcelo Lobosco · 2021 · Frontiers in Molecular Biosciences
91. Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects
    S. Lusvarghi, Wei Wang, Rachel Herrup, S. Neerukonda, R. Vassell, Lisa Bentley, A. Eakin, Karl J. Erlandson, C. Weiss · 2021 · bioRxiv
92. Identification of potent small molecule inhibitors of SARS-CoV-2 entry
    Sonia Mediouni, Huihui Mou, Yuka Otsuka, Joseph Anthony Jablonski, Robert Scott Adcock, Lalit Batra, Dong-Hoon Chung, Christopher Rood, Ian Mitchelle S. de Vera, Ronald J. Jr. Rahaim et al. · 2022 · SLAS DISCOVERY
93. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
    Hataf Khan, Helena Winstone, Jose M. Jiménez-Guardeño, Carl Graham, Katie J. Doores, Caroline Goujon, David A. Matthews, Andrew D. Davidson, Suzannah J. Rihn, Massimo Palmarini et al. · 2021 · PLoS Pathogens
94. Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
    Kavya Srinivasan, Ashutosh Kumar Pandey, Ashlena Livingston, Sundararajan Venkatesh · 2021 · Molecular Biomedicine
95. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro
    Mya Myat Ngwe Tun, Kazufumi Toume, Elizabeth Luvai, Khine Mya Nwe, Shusaku Mizukami, Kenji Hirayama, Katsuko Komatsu, Kouichi Morita · 2022 · Journal of Natural Medicines
96. Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys
    Heng Li, Lei Guo, Hui-Wen Zheng, Jing Li, Xin Zhao, Jia-Qi Li, Yan Liang, Fengmei Yang, Yu-Rong Zhao, Jin-Ling Yang et al. · 2021 · Bioconjugate chemistry
97. Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications
    Yuda Turana, Michael Nathaniel, Robert Shen, Soegianto Ali, Rajender R. Aparasu · 2021 · Brain Sciences
98. The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
    Yixin Xie, Wenhan Guo, Alan E Lopez-Hernandez, Shaolei Teng, Lin Li · 2022 · Pathogens
99. The role of antigen-presenting cells in the pathogenesis of COVID-19
    Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, Arezou Azadi, Ali Shamekh, Nima Hemmat, Taher Entezari‐Maleki, Hossein Bannazadeh Baghi · 2022 · Pathology - Research and Practice
100. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
     Yunjeong Kim, Natasha N. Gaudreault, David A. Meekins, Krishani Dinali Perera, Dashzeveg Bold, Jessie D. Trujillo, Igor Morozov, Chester D. McDowell, Kyeong‐Ok Chang, Jüergen A. Richt · 2022 · Microbiology Spectrum